WHAT THE C@H?! Trademark

Trademark Overview


On Monday, February 26, 2024, a trademark application was filed for WHAT THE C@H?! with the United States Patent and Trademark Office. The USPTO has given the WHAT THE C@H?! trademark a serial number of 98421458. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, May 21, 2026. This trademark is owned by Neurocrine Biosciences, Inc.. The WHAT THE C@H?! trademark is filed in the Advertising, Business and Retail Services, Communication Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

providing medical research information in the field of pharmaceuticals; providing medical research information in the field of pharmaceuticals and adrenal insufficiency

Promoting awareness of congenital adrenal hyperplasia by providing a public online platform in the nature of an online forum to discuss congenital adrenal hyperplasia and coping strategies; Promoting awareness of adrenal insufficiency by providing a public online platform in the nature of an online forum to discuss adrenal insufficiency and coping strategies; Promoting awareness of endocrine diseases and disorders by providing a public online platform in the nature of an online forum to discuss endocrine diseases and disorders and coping strategies

promoting awareness of congenital adrenal hyperplasia by providing a public in-person platform to discuss congenital adrenal hyperplasia and coping strategies; Promoting awareness of adrenal insufficiency and promoting awareness of adrenal insufficiency by providing a public in-person platform to discuss adrenal insufficiency and coping strategies; promoting awareness of endocrine diseases and disorders by providing a public in-person platform to discuss endocrine diseases and disorders and coping strategies; promoting the interests of people who have adrenal insufficiency and their families and health care providers by means of public advocacy; maintaining a registry of patients with congenital adrenal hyperplasia; maintaining a registry of patients with adrenal insufficiency; maintaining a registry of patients with endocrine diseases and ...

providing medical information to insurance companies in the field of congenital adrenal hyperplasia; providing medical information to patients, medical professionals, and insurance companies in the field of adrenal insufficiency; providing medical information to insurance companies in the field of endocrine diseases and disorders; online information services, namely, providing medical information in the field of adrenal insufficiency; Providing medical information in the nature of providing an in-person health forum for users to participate in discussions in the field of congenital adrenal hyperplasia; Providing medical information in the nature of providing an in-person health forum for users to participate in discussions in the field of adrenal insufficiency; Providing medical information in the nature of providing an in-person health forum f...
what the c@h?!

General Information


Serial Number98421458
Word MarkWHAT THE C@H?!
Filing DateMonday, February 26, 2024
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, May 21, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 8, 2025

Trademark Statements


Goods and Servicesproviding medical research information in the field of pharmaceuticals; providing medical research information in the field of pharmaceuticals and adrenal insufficiency
Goods and ServicesPromoting awareness of congenital adrenal hyperplasia by providing a public online platform in the nature of an online forum to discuss congenital adrenal hyperplasia and coping strategies; Promoting awareness of adrenal insufficiency by providing a public online platform in the nature of an online forum to discuss adrenal insufficiency and coping strategies; Promoting awareness of endocrine diseases and disorders by providing a public online platform in the nature of an online forum to discuss endocrine diseases and disorders and coping strategies
Goods and Servicespromoting awareness of congenital adrenal hyperplasia by providing a public in-person platform to discuss congenital adrenal hyperplasia and coping strategies; Promoting awareness of adrenal insufficiency and promoting awareness of adrenal insufficiency by providing a public in-person platform to discuss adrenal insufficiency and coping strategies; promoting awareness of endocrine diseases and disorders by providing a public in-person platform to discuss endocrine diseases and disorders and coping strategies; promoting the interests of people who have adrenal insufficiency and their families and health care providers by means of public advocacy; maintaining a registry of patients with congenital adrenal hyperplasia; maintaining a registry of patients with adrenal insufficiency; maintaining a registry of patients with endocrine diseases and disorders; updating and maintenance of information in registries, namely, administering a patient registry for patients with congenital adrenal hyperplasia; updating and maintenance of information in registries, namely, administering a patient registry for patients with adrenal insufficiency; updating and maintenance of information in registries, namely, administering a patient registry for patients with endocrine diseases and disorders
Pseudo MarkWHAT THE C AT H
Goods and Servicesproviding medical information to insurance companies in the field of congenital adrenal hyperplasia; providing medical information to patients, medical professionals, and insurance companies in the field of adrenal insufficiency; providing medical information to insurance companies in the field of endocrine diseases and disorders; online information services, namely, providing medical information in the field of adrenal insufficiency; Providing medical information in the nature of providing an in-person health forum for users to participate in discussions in the field of congenital adrenal hyperplasia; Providing medical information in the nature of providing an in-person health forum for users to participate in discussions in the field of adrenal insufficiency; Providing medical information in the nature of providing an in-person health forum for users to participate in discussions in the field of endocrine diseases and disorders

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, February 26, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class038 - Services allowing people to communicate with another by a sensory means.
US Class Codes100, 101, 104
Class Status Code6 - Active
Class Status DateMonday, February 26, 2024
Primary Code038
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 26, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 26, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
US

Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
US

Trademark Events


Event DateEvent Description
Monday, February 26, 2024NEW APPLICATION ENTERED
Friday, July 5, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 15, 2024ASSIGNED TO EXAMINER
Wednesday, August 28, 2024NON-FINAL ACTION WRITTEN
Wednesday, August 28, 2024NON-FINAL ACTION E-MAILED
Wednesday, August 28, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 12, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, November 12, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, February 27, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 7, 2025ASSIGNED TO LIE
Monday, March 10, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 10, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 14, 2025EXAMINERS AMENDMENT -WRITTEN
Friday, March 14, 2025EXAMINERS AMENDMENT E-MAILED
Friday, March 14, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 14, 2025EXAMINER'S AMENDMENT ENTERED
Friday, March 14, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 14, 2025LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 20, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 20, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 20, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 2, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 8, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 8, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 3, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 22, 2025TEAS STATEMENT OF USE RECEIVED
Wednesday, December 3, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, May 6, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 22, 2025TEAS REQUEST TO DIVIDE RECEIVED
Friday, August 22, 2025DIVISIONAL REQUEST RECEIVED
Wednesday, May 13, 2026DIVISIONAL PROCESSING COMPLETE
Tuesday, December 2, 2025SOU EXTENSION 1 FILED
Wednesday, May 13, 2026SOU EXTENSION 1 GRANTED
Wednesday, May 13, 2026CORRECTED NOA E-MAILED
Wednesday, May 13, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 15, 2026SOU TEAS EXTENSION RECEIVED
Thursday, May 14, 2026SOU EXTENSION 2 FILED
Thursday, May 21, 2026SOU EXTENSION 2 GRANTED
Friday, May 22, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED